KPRX
Kiora Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.15M
P/E Ratio
—
EPS
$-2.64
Beta
-0.47
52W High
$4.18
52W Low
$1.76
50-Day MA
$2.20
200-Day MA
$2.35
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.67
PEG Ratio
—
About Kiora Pharmaceuticals Inc
Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm dedicated to developing transformative therapies for ocular diseases and neurodegenerative disorders. The company's robust pipeline of innovative drug candidates aims to meet critical unmet medical needs, utilizing its advanced expertise in drug formulation and delivery systems to propel clinical trials toward regulatory approval. Kiora's focus on improving patient outcomes, complemented by strong research capabilities and strategic collaborations, enhances its competitive position within the biopharmaceutical sector, making it an appealing investment opportunity for institutional investors interested in pioneering therapeutics.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-3.71M |
| EBITDA | $-9.43M |
| Operating Margin | 0.00% |
| Return on Equity | -51.70% |
| Return on Assets | -19.50% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.29 |
| Price-to-Book | 0.66 |
| Price-to-Sales (TTM) | 0.82 |
| EV/Revenue | 13.31 |
| EV/EBITDA | -1.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.39M |
| Float | $3.83M |
| % Insiders | 3.05% |
| % Institutions | 18.27% |
Historical Volatility
HV 10-Day
36.67%
HV 20-Day
119.75%
HV 30-Day
100.35%
HV 60-Day
76.51%
HV Rank
85.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($12.00 target)
1
Strong BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026